Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.

Liakina, V;Hamid, S;Tanaka, J;Olafsson, S;Sharara, A I;Alavian, S M;Gheorghe, L;El Hassan, E S;Abaalkhail, F;Abbas, Z;Abdou, A;Abourached, A;Al Braiki, F;Al Hosani, F;Al Jaberi, K;Al Khatry, M;Al Mulla, M A;Al Quraishi, H;Al Rifai, A;Al Serkal, Y;Alam, A;Alashgar, H I;Alawadhi, S;Al-Dabal, L;Aldins, P;Alfaleh, F Z;Alghamdi, A S;Al-Hakeem, R;Aljumah, A A;Almessabi, A;Alqutub, A N;Alswat, K A;Altraif, I;Alzaabi, M;Andrea, N;Assiri, A M;Babatin, M A;Baqir, A;Barakat, M T;Bergmann, O M;Bizri, A R;Blach, S;Chaudhry, A;Choi, M S;Diab, T;Djauzi, S;El Khoury, S;Estes, C;Fakhry, S;Farooqi, J I;Fridjonsdottir, H;Gani, R A;Ghafoor Khan, A;Goldis, A;Gottfredsson, M;Gregorcic, S;Hajarizadeh, B;Han, K H;Hasan, I;Hashim, A;Horvath, G;Hunyady, B;Husni, R;Jafri, W;Jeruma, A;Jonasson, J G;Karlsdottir, B;Kim, D Y;Kim, Y S;Koutoubi, Z;Lesmana, L A;Lim, Y S;Löve, A;Maimets, M;Makara, M;Malekzadeh, R;Matičič, M;Memon, M S;Merat, S;Mokhbat, J E;Mourad, F H;Muljono, D H;Nawaz, A;Nugrahini, N;Priohutomo, S;Qureshi, H;Rassam, P;Razavi, H;Razavi-Shearer, D;Razavi-Shearer, K;Rozentale, B;Sadik, M;Saeed, K;Salamat, A;Salupere, R;Sanai, F M;Sanityoso Sulaiman, A;Sayegh, R A;Schmelzer, J D;Sibley, A;Siddiq, M;Siddiqui, A M;Sigmundsdottir, G;Sigurdardottir, B;Speiciene, D;Sulaiman, A;Sultan, M A;Taha, M;Tarifi, H;Tayyab, G;Tolmane, I;Ud Din, M;Umar, M;Valantinas, J;Videčnik-Zorman, J;Yaghi, C;Yunihastuti, E;Yusuf, M A;Zuberi, B F;Gunter, J;
journal of viral hepatitis 2015 Vol. 22 Suppl 4 pp. 4-20
360
liakina2015historicaljournal

Abstract

Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden.

Citation

ID: 55098
Ref Key: liakina2015historicaljournal
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
55098
Unique Identifier:
10.1111/jvh.12475
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet